Mean nocturia improvements were significantly superior ( p 0.01 ) with combination therapy than with either monotherapy ( adjusted mean change from baseline in IPSS Question 7 score at month 48 : combination therapy -0.5 , dutasteride -0.4 , tamsulosin -0.3 ) .